Status: Recruiting
Fecal Microbiota Transplant and Dietary Fiber Supplementation for the Treatment of Gut Graft Versus Host Disease
This phase I trial studies how well fecal microbiota transplant and dietary fiber supplementation work in treating patients with gut graft versus host disease. Fecal microbiota transplant entails inoculating donor stool into a recipient's gastrointestinal tract. Changing the gut microbiome by fecal microbiota transplant and fiber supplementation may help treat gut graft versus host disease.
Participants needed: 72
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Fred Hutchinson Cancer CenterUpdated: Sep 11, 2026Locations: 1
Eligibility criteria
18 years of age or older [+4]
History of previous serious adverse events associated with FMT [+12]